Huy X Ngo
Huy X Ngo
University of San Francisco
Verified email at
Cited by
Cited by
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents
NT Chandrika, SK Shrestha, HX Ngo, S Garneau-Tsodikova
Bioorganic & medicinal chemistry 24 (16), 3680-3686, 2016
A complex game of hide and seek: the search for new antifungals
HX Ngo, S Garneau-Tsodikova, KD Green
MedChemComm 7 (7), 1285-1306, 2016
Alkylated piperazines and piperazine-azole hybrids as antifungal agents
N Thamban Chandrika, SK Shrestha, HX Ngo, OV Tsodikov, KC Howard, ...
Journal of medicinal chemistry 61 (1), 158-173, 2018
Identification of ebsulfur analogues with broad-spectrum antifungal activity
HX Ngo, SK Shrestha, S Garneau-Tsodikova
ChemMedChem 11 (14), 1507, 2016
Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis …
A Garzan, MJ Willby, HX Ngo, CS Gajadeera, KD Green, SYL Holbrook, ...
ACS infectious diseases 3 (4), 302-309, 2017
Novel fluconazole derivatives with promising antifungal activity
NT Chandrika, SK Shrestha, HX Ngo, KC Howard, S Garneau-Tsodikova
Bioorganic & medicinal chemistry 26 (3), 573-580, 2018
What are the drugs of the future?
HX Ngo, S Garneau-Tsodikova
MedChemComm 9 (5), 757-758, 2018
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus
HX Ngo, SK Shrestha, KD Green, S Garneau-Tsodikova
Bioorganic & medicinal chemistry 24 (24), 6298-6306, 2016
Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4)
MS Frasinyuk, W Zhang, P Wyrebek, T Yu, X Xu, VM Sviripa, ...
Organic & biomolecular chemistry 15 (36), 7623-7629, 2017
Potent 1,2,4-Triazino[5,6b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis
HX Ngo, KD Green, CS Gajadeera, MJ Willby, SYL Holbrook, C Hou, ...
ACS infectious diseases 4 (6), 1030-1040, 2018
Interactions of oral molecular excipients with breast cancer resistance protein, BCRP
L Zou, J Pottel, N Khuri, HX Ngo, Z Ni, E Tsakalozou, MS Warren, ...
Molecular pharmaceutics 17 (3), 748-756, 2020
N, N′-diaryl-bishydrazones in a biphenyl platform: broad spectrum antifungal agents
NT Chandrika, EK Dennis, SK Shrestha, HX Ngo, KD Green, ...
European journal of medicinal chemistry 164, 273-281, 2019
Interfering with DNA decondensation as a strategy against mycobacteria
EM Scutigliani, ER Scholl, AE Grootemaat, S Khanal, JA Kochan, ...
Frontiers in microbiology 9, 2034, 2018
Flipping the Switch “On” for Aminoglycoside-Resistance Enzymes: The Mechanism Is Finally Revealed!
HX Ngo, S Garneau-Tsodikova
Structure 24 (7), 1011-1013, 2016
Predicted Magnetic Fields of Loop Currents for Cuprate Superconductivity: A MaxEnt-μSR GdBCO Study
T Songatikamas, C Boekema, J Wong, H Ngo, MC Browne
Journal of superconductivity and novel magnetism 23 (5), 793-797, 2010
Inhibition of Pseudomonas aeruginosa Alginate Synthesis by Ebselen Oxide and Its Analogues
SK Kim, HX Ngo, EK Dennis, N Thamban Chandrika, P DeShong, ...
ACS Infectious Diseases, 2021
Drug metabolites potently inhibit renal organic anion transporters, OAT1 and OAT3
L Zou, P Matsson, A Stecula, HX Ngo, AA Zur, KM Giacomini
Journal of pharmaceutical sciences 110 (1), 347-353, 2021
Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies
SW Yee, D Buitrago, A Stecula, HX Ngo, HC Chien, L Zou, ML Koleske, ...
The FASEB Journal 34 (12), 15734-15752, 2020
Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from Mycobacterium tuberculosis
A Punetha, HX Ngo, SYL Holbrook, KD Green, MJ Willby, SA Bonnett, ...
ACS chemical biology 15 (6), 1581-1594, 2020
Emerging targets in anti-tubercular drug design
KD Green, SYL Holbrook, HX Ngo, S Garneau-Tsodikova
Antibiotic Drug Discovery, 141-203, 2017
The system can't perform the operation now. Try again later.
Articles 1–20